# Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.

Study · id `cardio:ct-nct07762547` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07762547](<https://clinicaltrials.gov/study/NCT07762547>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07762547

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 724 participants.

## Technical summary

Registry record NCT07762547. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-15 (anticipated); primary completion 2030-02-28 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 724 participants (planned count; ClinicalTrials.gov record NCT07762547, source copy `cardio:ctgov-nct07762547-2026-08-13`, retrieved 2026-11-18)
- Planned start: 2026-07-15 (anticipated) (ClinicalTrials.gov record NCT07762547, source copy `cardio:ctgov-nct07762547-2026-08-13`, retrieved 2026-11-18)
- Primary completion: 2030-02-28 (anticipated) (ClinicalTrials.gov record NCT07762547, source copy `cardio:ctgov-nct07762547-2026-08-13`, retrieved 2026-11-18)
- Completion: 2030-02-28 (anticipated) (ClinicalTrials.gov record NCT07762547, source copy `cardio:ctgov-nct07762547-2026-08-13`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT07762547, source copy `cardio:ctgov-nct07762547-2026-08-13`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07762547-2026-08-13`, retrieved 2026-11-18)

## The registry's words

- Brief title: Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.
- Acronym: MOUNT-EASE
- Condition: Moyamoya Disease
- Condition: Moyamoya Syndrome
- Condition: Aspirin
- Condition: Remote Ischemic Conditioning
- Intervention (Drug): aspirin treatment
- Intervention (Drug): Aspirin placebo
- Intervention (Device): Remote Ischemic Conditioning
- Intervention (Device): Sham remote ischemic conditioning
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Moyamoya disease (`cardio:moyamoya-disease`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: c814ff17c119b5473fd44ed027ecd346923b2ccae66f067cfb813d5143f48152
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
